Table 1.
Relationships Between DAB2IP Expression and Clinic-Pathological Factors in 59 GC Patients
| Variables | Case No. | DAB2IP Expression | Χ2 | P value | |
|---|---|---|---|---|---|
| None or Low | High | ||||
| Total | 59 | 39 (66.1%) | 20 (33.9%) | ||
| Age | |||||
| <65 | 30 | 20 (66.7%) | 10 (33.3%) | 0.009 | 0.926 |
| ≥65 | 29 | 19 (30.0%) | 10 (70.0%) | ||
| Gender | |||||
| Male | 39 | 24 (61.5%) | 15 (38.5%) | 1.069 | 0.301 |
| Female | 20 | 15 (75.0%) | 5 (25.0%) | ||
| Tumor size | |||||
| <5cm | 27 | 14 (51.9%) | 13 (48.1%) | 4.511 | 0.034* |
| ≥5cm | 32 | 25 (78.1%) | 7 (21.9%) | ||
| Tumor location | |||||
| U | 33 | 24 (72.7%) | 9 (27.3%) | 1.467 | 0.226 |
| L | 26 | 15 (57.7%) | 11 (42.3%) | ||
| Degree of differentiation | |||||
| Well | 25 | 11 (44.0%) | 14 (56.0%) | 9.457 | 0.002** |
| Poor | 34 | 28 (82.4%) | 6 (17.6%) | ||
| Depth of invasion | |||||
| T1–2 | 13 | 4 (30.8%) | 9 (69.2%) | - | 0.006** |
| T3–4 | 46 | 35 (76.1%) | 11 (23.9%) | ||
| Lymph node metastasis | |||||
| No | 17 | 4 (23.5%) | 13 (76.5%) | 19.316 | <0.001*** |
| Yes | 42 | 35 (83.3%) | 7 (16.7%) | ||
| TNM stage | |||||
| I/II | 19 | 5 (26.3%) | 14 (73.7%) | 19.798 | <0.001*** |
| III/IV | 40 | 34 (85.0%) | 6 (15.0%) | ||
Notes: *P<0.05; **P<0.01; ***P<0.001.